Lilly wins panel's backing to expand Cymbalta use | Indianapolis Business Journal | IBJ.com
Links shared publicly online about this topic.
- 935total visits
Lilly wins panel's backing to expand Cymbalta use | Indianapolis Business Journal | IBJ.com
ibj.com —
Eli Lilly and Co., the drugmaker whose top three products face generic competition within three years, won a U.S. panel’s backing to expand use of the antidepressant Cymbalta in chronic knee and back pain. Outside advisers to the Food and Drug Administration voted 8-6 Thursday in Bethesda, Md., in favor of a broader use of Cymbalta on the basis of studies in lower back pain and osteoarthritis of the knee. The FDA usually follows its panels’ recommendations, though it isn’t requ
View full resource at ibj.com
Tags: Anxiety Medication, Antidepressant, Fibromyalgia Medication, Neuropathic Pain Medication, Drug, FDA, Cymbalta
Most Recently Shared on August 19, 2010 at 11:10 pm By:
Lilly gains panel's backing to expand Cymbalta use: Outside advisers to the Food and Drug Administration voted 8-6... http://bit.ly/9wdbD0
Advertisement
